References
- Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40. https://doi.org/10.1056/NEJM199612263352601
- Sohn JW, Shin DG, Kim DH, et al. Non-invasive parameters, including a low left ventricular ejection fraction, for predicting sudden cardiac death in Korean post myocardial infarction patients. Korean Circ J 2006; 36:431-6.
- Vlay SC. The ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: their relevance to the cardiologist, internist and family physician. J Invasive Cardiol 2009;21:234-7.
- Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83. https://doi.org/10.1056/NEJMoa013474
- Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 2004;43:1459-65. https://doi.org/10.1016/j.jacc.2003.11.038
- Kadish A, Dyer A, Daubert JP, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151-8. https://doi.org/10.1056/NEJMoa033088
- Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008;117:e350-408. https://doi.org/10.1161/CIRCUALTIONAHA.108.189742
- Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001;104:2158-63. https://doi.org/10.1161/hc4301.098254
- Tanno K, Miyoshi F, Watanabe N, et al. Are the MADIT II criteria for ICD implantation appropriate for Japanese patients? Circ J 2005;69:19-22. https://doi.org/10.1253/circj.69.19
- Siu CW, Pong V, Ho HH, et al. Are MADIT II criteria for implantable cardioverter defibrillator implantation appropriate for Chinese patients? J Cardiovasc Electrophysiol 2010;21:231-5. https://doi.org/10.1111/j.1540-8167.2009.01609.x
- Ng AC, Sindone AP, Wong HS, Freedman SB. Differences in management and outcome of ischemic and non-ischemic cardiomyopathy. Int J Cardiol 2008;129:198-204. https://doi.org/10.1016/j.ijcard.2007.07.014
- Solomon SD, Zelenkofske S, McMurray JJ, et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005;352:2581-8. https://doi.org/10.1056/NEJMoa043938
- Han SW, Ryu KH, Chae SC, et al. Multicenter analysis of clinical characteristics and prognostic factors of patients with congestive heart failure in Korea. Korean Circ J 2005;35:357-61.
- Cesario DA, Dec GW. Implantable cardioverter-defibrillator therapy in clinical practice. J Am Coll Cardiol 2006;47:1507-17. https://doi.org/10.1016/j.jacc.2005.09.077
- The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:331-6. https://doi.org/10.1056/NEJM198308113090602
- Sung YN, Jang SM, Lim DH, Shin SY, Song HJ, Lee SH. Prescribing Patterns of Antihypertensive Drugs by Outpatients with Hypertension in 2007. Korean J Clin Pharmacol 2009;19:167-79.
- Remme WJ, McMurray JJ, Hobbs FD, et al. Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians. Eur Heart J 2008;29:1739-52. https://doi.org/10.1093/eurheartj/ehn196
- Doehner W, Rauchhaus M, Ponikowski P, et al. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol 2005;46:1019-26. https://doi.org/10.1016/j.jacc.2005.02.093
- McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 2004;109:1004-9. https://doi.org/10.1161/01.CIR.0000116764.53225.A9
- Ahmed A, Rich MW, Sanders PW, et al. Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol 2007;99:393-8. https://doi.org/10.1016/j.amjcard.2006.08.042
- Bonow RO, Smaha LA, Smith SC Jr, Mensah GA, Lenfant C. World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation 2002;106:1602-5. https://doi.org/10.1161/01.CIR.0000035036.22612.2B
- Mason NA, Bailie GR, Satayathum S, et al. HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients. Am J Kidney Dis 2005;45:119-26. https://doi.org/10.1053/j.ajkd.2004.09.025
- Mozaffarian D, Nye R, Levy WC. Statin therapy is associated with lower mortality among patients with severe heart failure. Am J Cardiol 2004; 93:1124-9. https://doi.org/10.1016/j.amjcard.2004.01.039
Cited by
- Disparity Between Indications for and Utilization of Implantable Cardioverter Defibrillators in Asian Patients With Heart Failure vol.10, pp.11, 2012, https://doi.org/10.1161/circoutcomes.116.003651
- Temporal Trends of Cardiac Implantable Electronic Device Implantations: a Nationwide Population-based Study vol.49, pp.9, 2012, https://doi.org/10.4070/kcj.2018.0444